$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon & Co. 2022 Q4 - Results - Earnings Call Presentation
04:47pm, Thursday, 17'th Feb 2022 Seeking AlphaMerck Spinoff Organon Beats Quarterly Views, But Offers Dim Guidance
02:03pm, Thursday, 17'th Feb 2022 Investor''s Business Daily
Organon topped fourth-quarter estimates Thursday, but OGN stock fell on lighter-than-expected 2022 sales guidance.
Organon & Co. (OGN) CEO Kevin Ali on Q4 2021 Results - Earnings Call Transcript
01:19pm, Thursday, 17'th Feb 2022
Organon & Co. (OGN) CEO Kevin Ali on Q4 2021 Results - Earnings Call Transcript
Established Brands Hit Organon''s Q4 Sales, Expects FY22 Sales Of Upto $6.4B
12:47pm, Thursday, 17'th Feb 2022 Benzinga
Organon & Co''s (NYSE: OGN ) Q4 FY21 sales decreased 1% to $1.6 billion , beating the consensus of $1.57 billion. Women''s Health increased 6%, driven primarily by Nexplanon, which increased 37% ex-FX. Nexplanon''s growth was due to increased demand in the U.S., and tenders won. The increase in Women''s Health was partially offset by a decline … Full story available on Benzinga.com
Organon declares $0.28 dividend
12:38pm, Thursday, 17'th Feb 2022 Seeking Alpha
Organon (OGN) declares $0.28/share quarterly dividend, in line with previous…......................
Organon projects in-line guidance for 2022 as topline and bottom-line contract
12:28pm, Thursday, 17'th Feb 2022 Seeking Alpha
Organon (OGN) set its 2022 revenue in line with Wall Street forecasts even as the contraction in its topline and the bottom line continued for another quarter in Q4 2021
Organon Non-GAAP EPS of $1.37 beats by $0.10, revenue of $1.6B beats by $20M
11:31am, Thursday, 17'th Feb 2022 Seeking Alpha
Organon press release (OGN): Q4 Non-GAAP EPS of $1.37 beats by $0.10.Revenue of $1.6B (-0.6% Y/Y) beats by $20M.FY22 Guidance:Revenue of $6.1-$6.4B vs
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
11:30am, Thursday, 17'th Feb 2022 Business Wire
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon reports results for the fourth quarter and full year ended December 31, 2021
Earnings Scheduled For February 17, 2022
10:02am, Thursday, 17'th Feb 2022 Benzinga
Companies Reporting Before The Bell • Palantir Technologies (NYSE: PLTR ) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. • Organon (NYSE: OGN ) is expected to report quarterly earnings at $1.24 per share on revenue of $1.57 billion. • Perella Weinberg Partners (NASDAQ: PWP ) is likely to report quarterly earnings at $0.30 per share on revenue of $193.75 million. • Navios Maritime Partners (NYSE: NMM ) is estimated to report quarterly earnings at $4.35 per share on revenue of $272.59 million. • Portland General Electric (NYSE: POR ) is likely to report quarterly earnings at $0.76 per share on revenue of $533.13 million. • Frontline (NYSE: FRO ) is estimated to report quarterly earnings at $0.13 per share on revenue of $111.30 million. • R1 RCM (NASDAQ: RCM ) is estimated to report quarterly earnings at $0.11 per share on revenue of $399.26 million. • Fiverr International (NYSE: FVRR ) is likely to report quarterly earnings at $0.04 per share on revenue of $76.
Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto $6.4B
07:47am, Thursday, 17'th Feb 2022
Organon & Co's (NYSE: OGN) Q4 FY21 sales decreased 1% to $1.6 billion, beating the consensus of $1.57 billion. Women's Health increased 6%, driven primarily by Nexplanon, which increased 37% ex-FX.
Organon & Co.’s Stock Gains 1.82%, But It May Still Be Worth Investing In.
07:00pm, Wednesday, 16'th Feb 2022 Stocks Register
The trading price of Organon & Co. (NYSE:OGN) floating higher at last check on Wednesday, February 16, closing at $35.86, 1.82% higher than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it … Organon & Co.’s Stock Gains 1.82%, But It May Still Be Worth Investing In. Read More »
Will Organon Q4 earnings bring positive surprise?
04:04pm, Wednesday, 16'th Feb 2022 Seeking Alpha
Organon (NYSE:OGN) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open.The consensus EPS Estimate is $1.27 and the consensus Revenue Estimate…
Organon acquires rights for oral contraceptive pills in China from Bayer
01:55pm, Wednesday, 16'th Feb 2022 Seeking Alpha
Organon (OGN) announced on Wednesday that the company acquired the rights for Marvelon and Mercilon combined oral hormonal daily contraceptive pills in China (including Hong Kong and…
5 Best Dow Dividend Stocks to Buy Now
07:40pm, Monday, 14'th Feb 2022 Kiplinger
If there''s one thing recent macroeconomic and stock market turbulence should reteach us, it''s that the best blue-chip dividend stocks never go out of style. And the Dow''s best dividend stocks are proving that handily so far in 2022. True, inflation is advancing at the fastest pace in four decades, and the market is seething with anxiety over impending interest rate hikes. Yet the top-rated dividend payers among the 30 Dow Jones stocks are beating the market so far this year and should continue to give income investors some much-needed peace of mind. SEE MORE The Pros Picks: 22 Top Stocks to Invest In for 2022 Many of the Dow''s best dividend stocks also happen to be dividend growth stalwarts. Quite a few names in this elite bastion of 30 blue-chip equities are members of the S&P 500 Dividend Aristocrats an index of 66 best dividend stocks that have increased their payouts for at least 25 consecutive years. It''s also noteworthy that the Dow Jones'' best dividend stocks hail from sectors that hold up well when inflation runs hot .
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?
05:10pm, Monday, 14'th Feb 2022 Zacks Investment Research
Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sign In
Buy OGN